Pharmigene, Inc.

Pharmigene, Inc.verified

7595.TWO

Price:

$10.4

Market Cap:

$524.90M

Pharmigene, Inc. designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally. It offers molecular diagnostics to test adverse drug reactions; and DNA extraction products for gene expression analysis, clinical molecular diagnosis, human identity testing, forensics, and biomedical research applications. The company also provides pharmacogenomics test, drug allergy test, and functional medicine test services. In addition, it distributes various genomics and genetics equipment and reagents; and provides professional consultation, training program, analysis software, and technical support solutions. Further, the company offers CDMO services. The company was founded i...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-12-22

Stock Exchange

TWO

Ticker

7595.TWO

The PE Ratio as of December 2025 (TTM) for Pharmigene, Inc. (7595.TWO) is -6.93

According to Pharmigene, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.93. This represents a change of 45.20% compared to the average of -4.77 of the last 4 quarters.

Pharmigene, Inc. (7595.TWO) Historical PE Ratio (quarterly & annually)

How has 7595.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Pharmigene, Inc. over the last ten years is -28.62. The current -6.93 PE Ratio has changed 2.32% with respect to the historical average. Over the past ten years (40 quarters), 7595.TWO's PE Ratio was at its highest in in the June 2025 quarter at -3.68. The PE Ratio was at its lowest in in the December 2020 quarter at -37.51.

Quarterly (TTM)
Annual

Average

-28.62

Median

-17.61

Minimum

-75.02

Maximum

-8.68

Pharmigene, Inc. (7595.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pharmigene, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 385.97%

Maximum Annual PE Ratio = -8.68

Minimum Annual Increase = -50.14%

Minimum Annual PE Ratio = -75.02

Quarterly (TTM)
Annual
YearPE RatioChange
2024-8.68-33.88%
2023-13.13-33.68%
2022-19.79-50.14%
2021-39.69-47.09%
2020-75.02385.97%

Pharmigene, Inc. (7595.TWO) Average PE Ratio

How has 7595.TWO PE Ratio performed in the past?

The current PE Ratio of Pharmigene, Inc. (7595.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-13.86

5-year avg

-31.26

10-year avg

-28.62

Pharmigene, Inc. (7595.TWO) PE Ratio vs. Peers

How is 7595.TWO’s PE Ratio compared to its peers?

Pharmigene, Inc.’s PE Ratio is greater than UniPharma Co., Ltd. (-10.97), less than Taiwan Advanced Nanotech Inc. (-2.28), greater than DuoGenic StemCells corporation (-13.76), greater than Sunder Biomedical Tech. Co., Ltd. (-50.25), less than A-SPINE Asia Co., Ltd. (53.12), less than Bioray Biotech Co., Ltd (20.56), greater than Health & Life Co., Ltd. (-37.83), less than Welgene Biotech Co.,Ltd. (185.95), greater than Original BioMedicals Co., Ltd. (-10.78), greater than Vectorite Biomedical Inc. (-27.18),

Build a custom stock screener for Pharmigene, Inc. (7595.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmigene, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharmigene, Inc. (7595.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharmigene, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Pharmigene, Inc.'s PE Ratio?

How is the PE Ratio calculated for Pharmigene, Inc. (7595.TWO)?

What is the highest PE Ratio for Pharmigene, Inc. (7595.TWO)?

What is the 3-year average PE Ratio for Pharmigene, Inc. (7595.TWO)?

What is the 5-year average PE Ratio for Pharmigene, Inc. (7595.TWO)?

How does the current PE Ratio for Pharmigene, Inc. (7595.TWO) compare to its historical average?